The Stribild single-tablet regimen matched both Atripla and boosted atazanavir in efficacy among people age 50 and older, who responded as well as younger patients, researchers reported at the recent 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver.
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/4319-icaac-2013-stribild-is-effective-and-well-tolerated-in-older-people-with-hiv
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/4319-icaac-2013-stribild-is-effective-and-well-tolerated-in-older-people-with-hiv
No comments:
Post a Comment